The Food and Drug Administration is raising concerns about the long-term effects of CBD.

Share:
More In Science
Alzheimer’s Drug Leqembi Receives Full FDA Approval
U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
Load More